Legal & General Group
ALXN

Legal & General Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,758,060
Closed -$323M 3533
2021
Q2
$323M Buy
1,758,060
+315,094
+22% +$57.9M 0.11% 208
2021
Q1
$221M Sell
1,442,966
-23,976
-2% -$3.67M 0.08% 283
2020
Q4
$229M Buy
1,466,942
+39,940
+3% +$6.24M 0.09% 250
2020
Q3
$163M Sell
1,427,002
-2,320
-0.2% -$265K 0.07% 297
2020
Q2
$160M Buy
1,429,322
+42,151
+3% +$4.73M 0.08% 288
2020
Q1
$125M Buy
1,387,171
+55,613
+4% +$5M 0.07% 286
2019
Q4
$144M Buy
1,331,558
+54,648
+4% +$5.91M 0.07% 322
2019
Q3
$125M Sell
1,276,910
-4,349
-0.3% -$426K 0.07% 327
2019
Q2
$168M Sell
1,281,259
-7,530
-0.6% -$986K 0.09% 255
2019
Q1
$174M Buy
1,288,789
+257,964
+25% +$34.9M 0.1% 235
2018
Q4
$100M Buy
1,030,825
+70,099
+7% +$6.82M 0.08% 280
2018
Q3
$134M Buy
960,726
+13,631
+1% +$1.89M 0.1% 244
2018
Q2
$118M Sell
947,095
-44,469
-4% -$5.52M 0.09% 251
2018
Q1
$111M Sell
991,564
-35,874
-3% -$4M 0.08% 268
2017
Q4
$123M Sell
1,027,438
-18,961
-2% -$2.27M 0.09% 254
2017
Q3
$147M Buy
1,046,399
+21,643
+2% +$3.04M 0.11% 216
2017
Q2
$125M Buy
1,024,756
+21,915
+2% +$2.67M 0.1% 230
2017
Q1
$122M Buy
1,002,841
+39,061
+4% +$4.74M 0.1% 227
2016
Q4
$118M Buy
963,780
+11,913
+1% +$1.46M 0.11% 217
2016
Q3
$117M Buy
951,867
+3,310
+0.3% +$406K 0.12% 207
2016
Q2
$111M Buy
948,557
+28,037
+3% +$3.27M 0.12% 208
2016
Q1
$128M Buy
920,520
+35,267
+4% +$4.91M 0.14% 165
2015
Q4
$169M Sell
885,253
-11,175
-1% -$2.13M 0.19% 125
2015
Q3
$140M Buy
896,428
+52,444
+6% +$8.2M 0.17% 144
2015
Q2
$153M Buy
843,984
+73,438
+10% +$13.3M 0.18% 137
2015
Q1
$134M Buy
770,546
+4,327
+0.6% +$750K 0.16% 154
2014
Q4
$142M Sell
766,219
-23,180
-3% -$4.29M 0.17% 141
2014
Q3
$131M Sell
789,399
-33,928
-4% -$5.63M 0.16% 154
2014
Q2
$129M Buy
823,327
+7,338
+0.9% +$1.15M 0.15% 165
2014
Q1
$124M Buy
815,989
+8,771
+1% +$1.33M 0.15% 163
2013
Q4
$107M Sell
807,218
-7,699
-0.9% -$1.02M 0.13% 186
2013
Q3
$94.7M Sell
814,917
-7,749
-0.9% -$900K 0.12% 194
2013
Q2
$75.9M Buy
+822,666
New +$75.9M 0.1% 224